Biohaven Pharmaceutical Holding Co Ltd (BHVN)

NYSE
18.19
-0.98(-5.11%)
After Hours
18.20
+0.01(+0.05%)
- Real-time Data
  • Volume:
    704,152
  • Day's Range:
    18.15 - 19.66
  • 52 wk Range:
    5.54 - 20.57

BHVN Overview

Prev. Close
19.17
Day's Range
18.15-19.66
Revenue
533.93M
Open
18.89
52 wk Range
5.54-20.57
EPS
-6.18
Volume
704,152
Market Cap
1.15B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,091,458
P/E Ratio
-2.49
Beta
-
1-Year Change
-85.91%
Shares Outstanding
68,160,979
Next Earnings Date
Mar 01, 2023
What is your sentiment on Biohaven Pharma?
or
Market is currently closed. Voting is open during market hours.

Biohaven Pharmaceutical Holding Co Ltd News

Biohaven Pharmaceutical Holding Co Ltd Analysis

Biohaven Pharmaceutical Holding Co Ltd Company Profile

Biohaven Pharmaceutical Holding Co Ltd Company Profile

Employees
928

Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company combines a deep understanding of neuroscience, immunology, disease-related biology, advanced chemistry, and expertise in global clinical trials to advance novel therapies for patients. The Company is engaged in delivering new drug approvals for products for diseases such as migraine and schizophrenia, and its research programs, built on a deep understanding of disease-related biology and neuropharmacology, are advancing novel therapies with indications in spinocerebellar ataxia (SCA), amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), epilepsy, depression, obsessive-compulsive disorder (OCD) and neuropathic pain. Its Neuroinnovation portfolio includes a broad pipeline of drug candidates modulating distinct nervous system targets, including Kv7 ion channels (Kv7), glutamate receptors, myeloperoxidase (MPO), myostatin, and transient receptor potential (TRP) channels.

Read More

Analyst Price Target

Average24.20 (+33.04% Upside)
High27.00
Low21.00
Price18.19
No. of Analysts5
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellBuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellBuyBuy
SummaryStrong SellStrong SellStrong SellBuyStrong Buy
  • scam
    1
    • WOW!!!!!!
      1
      • overbought but good as long term investment
        0
        • Market Cap 5.45B, Revenue 28.51M...DUUUMP!!!
          1
          • khloe Kardashian promoting on ABC the View.
            0
            • $BHVN Buy this before the Phase 3 data announcement TRORILUZOLE and Rimegepant this month! I am assuming 2/20 or so..This stock can go to $80's.
              0
              • What is the special event on 20th Feb?
                0
            • stock tanked 35% today
              0